+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Blood Transfusion Diagnostics Market - Global Forecast 2026-2032- Product Image
Blood Transfusion Diagnostics Market - Global Forecast 2026-2032- Product Image
New

Blood Transfusion Diagnostics Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 184 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6010986
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The blood transfusion diagnostics market is evolving rapidly, as advances in detection technology, regulatory requirements, and operational practices increase the criticality of transfusion safety to health system resilience. Senior decision-makers must navigate shifting landscapes of risk, compliance, and technology adoption to ensure continued reliability and quality in blood services.

Market Snapshot: Blood Transfusion Diagnostics Market Overview

The Blood Transfusion Diagnostics Market expanded from USD 4.21 billion in 2025 to USD 4.61 billion in 2026. The market is projected to sustain a CAGR of 10.19% through 2032, reaching USD 8.32 billion. Growth reflects a sharp focus on strengthening clinical safety, optimizing operational workflows, and supporting regulatory compliance in transfusion practices at a global scale. Increasing regulatory scrutiny and the integration of innovative diagnostic technologies are driving significant changes across both mature and emerging markets.

Scope & Segmentation of the Blood Transfusion Diagnostics Market

This comprehensive analysis offers senior leaders a detailed breakdown of market structure, empowering informed investment and operational choices as clinical and regulatory standards advance.

  • Product Types: Encompasses instruments such as nucleic acid analyzers, serology workstations, and pathogen reduction platforms. Also includes essential consumables, daily-use accessories, and a full array of reagents and kits that affect testing accuracy and reliability.
  • Diagnostic Technologies: Covers molecular nucleic acid testing; serological assays, including ELISA, CLIA, and lateral flow assays; multiplex detection platforms; and advanced pathogen reduction techniques relevant to risk mitigation.
  • End Users: Comprises hospital blood banks focused on traceability and integration requirements, independent laboratories balancing costs and service scope, and research institutes emphasizing adaptability and innovation in diagnostic platforms.
  • Applications: Spans donation screening, quality control, transfusion safety implementation, immunohematology analysis, blood group typing, viral marker assays, pathogen inactivation, and routine proficiency validation by laboratories.
  • Regions: Includes the Americas, Europe, Middle East & Africa, and Asia-Pacific, each bringing unique regulatory, infrastructure, and maturity dimensions to the blood transfusion diagnostics ecosystem.

Each segment offers distinct value propositions. For example, automation in product platforms addresses immediate workflow bottlenecks, while localized regulatory requirements in different regions drive tailored approaches to compliance and partnership strategy.

Key Takeaways for Senior Decision-Makers

  • Diagnostics are transitioning from single-use screening tools to integrated, strategic platforms supporting broader patient safety and operational oversight.
  • Deployment of digital health integration, automation, and AI-enabled analytics is increasing the speed and reliability of clinical decision-making, while enabling near-real-time workflow improvements.
  • The intersection of regulatory demand and supply chain transparency means organizations need robust systems for validation, ongoing quality assurance, and traceability.
  • Segmented solutions—aligned with technology trends and market requirements—optimize resource utilization and adaptability across diverse clinical landscapes, enabling operational scalability as needs shift.
  • Regional differences in maturity and regulation actively shape technology rollouts, partnership models, and supplier localization strategies, with cross-regional insights becoming increasingly valuable.

Evaluating these emerging dynamics is key for leaders committed to enhancing service reliability, risk resilience, and ongoing compliance in diagnostics delivery.

Tariff Impact: Navigating Policy-Driven Supply Chain Risks

Recent tariff adjustments have increased landed costs for a wide range of diagnostic solutions. In response, many organizations are shifting procurement to regional and localized suppliers, as well as reviewing and renegotiating long-term service contracts. These changes reinforce the need for precise customs classification and diligent origin verification. Policy-driven challenges are also accelerating investment in regional manufacturing, fundamentally altering the planning and deployment of procurement and supply chain strategies for blood transfusion diagnostics.

Methodology & Data Sources

The research approach includes interviews with laboratory executives, procurement authorities, and technology solution providers. Cross-referencing industry literature, regulatory documentation, and vendor materials ensures reliability. Strategic gleanings are triangulated and validated through expert feedback to deliver actionable recommendations.

Why This Report Matters

  • Equips leadership with intelligence for timely procurement decisions, technology selection, and regulatory readiness in a dynamic market environment.
  • Facilitates risk and continuity planning by highlighting supply chain diversification, validation procedures, and responses to shifting regional frameworks.
  • Provides detailed segmentation to support operational strategy, partnership evaluation, and investment allocation based on emerging opportunities and threats.

Conclusion

Modern blood transfusion diagnostics support a resilient, safe, and efficient ecosystem. This report delivers the clarity senior decision-makers need to invest effectively and adapt confidently as the diagnostic landscape evolves.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Blood Transfusion Diagnostics Market, by Product
8.1. Consumables & Accessories
8.1.1. Microplates
8.1.2. Pipette Tips
8.2. Instruments
8.2.1. Nat Analyzers
8.2.2. Pathogen Reduction Systems
8.2.3. Serology Analyzers
8.3. Reagents & Kits
8.3.1. Amplification Reagents
8.3.2. Antibody Reagents
8.3.3. Dna Extraction Kits
9. Blood Transfusion Diagnostics Market, by Technology
9.1. Nucleic Acid Testing
9.1.1. Pcr
9.1.2. Real Time Pcr
9.1.3. Transcription Mediated Amplification
9.2. Pathogen Reduction Technology
9.2.1. Amotosalen
9.2.2. Methylene Blue
9.2.3. Riboflavin
9.3. Serological Testing
9.3.1. Clia
9.3.2. Elisa
9.3.3. Lateral Flow Assays
10. Blood Transfusion Diagnostics Market, by Application
10.1. Donation Screening
10.1.1. Immunohematology Testing
10.1.2. Viral Marker Screening
10.2. Quality Control
10.2.1. External Proficiency Testing
10.2.2. Internal Quality Control
10.3. Transfusion Safety
10.3.1. Blood Group Typing
10.3.2. Pathogen Inactivation
11. Blood Transfusion Diagnostics Market, by End User
11.1. Hospital Blood Banks
11.2. Independent Laboratories
11.3. Research Institutes
12. Blood Transfusion Diagnostics Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Blood Transfusion Diagnostics Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Blood Transfusion Diagnostics Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Blood Transfusion Diagnostics Market
16. China Blood Transfusion Diagnostics Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Abbott Laboratories
17.6. BAG Health Care GmbH
17.7. Becton, Dickinson and Company
17.8. Bio-Rad Laboratories, Inc.
17.9. bioMérieux SA
17.10. Danaher Corporation
17.11. DiaSorin S.p.A.
17.12. F. Hoffmann-La Roche Ltd
17.13. Grifols, S.A.
17.14. Immucor, Inc.
17.15. Ortho Clinical Diagnostics, Inc.
17.16. QuidelOrtho Corporation
17.17. Quotient Limited
17.18. Siemens Healthineers AG
17.19. Thermo Fisher Scientific Inc.
17.20. Werfen S.A.
List of Figures
FIGURE 1. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY MICROPLATES, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY MICROPLATES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY MICROPLATES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PIPETTE TIPS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PIPETTE TIPS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PIPETTE TIPS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NAT ANALYZERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NAT ANALYZERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NAT ANALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGY ANALYZERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGY ANALYZERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGY ANALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY AMPLIFICATION REAGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY AMPLIFICATION REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY AMPLIFICATION REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY ANTIBODY REAGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY ANTIBODY REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY ANTIBODY REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DNA EXTRACTION KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DNA EXTRACTION KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DNA EXTRACTION KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSCRIPTION MEDIATED AMPLIFICATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSCRIPTION MEDIATED AMPLIFICATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSCRIPTION MEDIATED AMPLIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY AMOTOSALEN, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY AMOTOSALEN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY AMOTOSALEN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY METHYLENE BLUE, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY METHYLENE BLUE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY METHYLENE BLUE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY RIBOFLAVIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY RIBOFLAVIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY RIBOFLAVIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CLIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CLIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CLIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY ELISA, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY ELISA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY ELISA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY IMMUNOHEMATOLOGY TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY IMMUNOHEMATOLOGY TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY IMMUNOHEMATOLOGY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY VIRAL MARKER SCREENING, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY VIRAL MARKER SCREENING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY VIRAL MARKER SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY EXTERNAL PROFICIENCY TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY EXTERNAL PROFICIENCY TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY EXTERNAL PROFICIENCY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INTERNAL QUALITY CONTROL, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INTERNAL QUALITY CONTROL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INTERNAL QUALITY CONTROL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY BLOOD GROUP TYPING, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY BLOOD GROUP TYPING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY BLOOD GROUP TYPING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN INACTIVATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN INACTIVATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN INACTIVATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY HOSPITAL BLOOD BANKS, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY HOSPITAL BLOOD BANKS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY HOSPITAL BLOOD BANKS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INDEPENDENT LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INDEPENDENT LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INDEPENDENT LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 121. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 122. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 123. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2018-2032 (USD MILLION)
TABLE 124. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 125. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 126. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 127. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2018-2032 (USD MILLION)
TABLE 128. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 129. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2018-2032 (USD MILLION)
TABLE 130. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 131. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2018-2032 (USD MILLION)
TABLE 132. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, 2018-2032 (USD MILLION)
TABLE 133. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, 2018-2032 (USD MILLION)
TABLE 134. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 135. NORTH AMERICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 136. NORTH AMERICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 137. NORTH AMERICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2018-2032 (USD MILLION)
TABLE 138. NORTH AMERICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 139. NORTH AMERICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 140. NORTH AMERICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 141. NORTH AMERICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2018-2032 (USD MILLION)
TABLE 142. NORTH AMERICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 143. NORTH AMERICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2018-2032 (USD MILLION)
TABLE 144. NORTH AMERICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 145. NORTH AMERICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2018-2032 (USD MILLION)
TABLE 146. NORTH AMERICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, 2018-2032 (USD MILLION)
TABLE 147. NORTH AMERICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, 2018-2032 (USD MILLION)
TABLE 148. NORTH AMERICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 149. LATIN AMERICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 150. LATIN AMERICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 151. LATIN AMERICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2018-2032 (USD MILLION)
TABLE 152. LATIN AMERICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 153. LATIN AMERICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 154. LATIN AMERICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 155. LATIN AMERICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2018-2032 (USD MILLION)
TABLE 156. LATIN AMERICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 157. LATIN AMERICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2018-2032 (USD MILLION)
TABLE 158. LATIN AMERICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 159. LATIN AMERICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2018-2032 (USD MILLION)
TABLE 160. LATIN AMERICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, 2018-2032 (USD MILLION)
TABLE 161. LATIN AMERICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, 2018-2032 (USD MILLION)
TABLE 162. LATIN AMERICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2018-2032 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2018-2032 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2018-2032 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2018-2032 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, 2018-2032 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, 2018-2032 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 177. EUROPE BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 178. EUROPE BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 179. EUROPE BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2018-2032 (USD MILLION)
TABLE 180. EUROPE BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 181. EUROPE BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 182. EUROPE BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 183. EUROPE BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2018-2032 (USD MILLION)
TABLE 184. EUROPE BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 185. EUROPE BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2018-2032 (USD MILLION)
TABLE 186. EUROPE BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 187. EUROPE BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2018-2032 (USD MILLION)
TABLE 188. EUROPE BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, 2018-2032 (USD MILLION)
TABLE 189. EUROPE BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, 2018-2032 (USD MILLION)
TABLE 190. EUROPE BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 191. MIDDLE EAST BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 192. MIDDLE EAST BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 193. MIDDLE EAST BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2018-2032 (USD MILLION)
TABLE 194. MIDDLE EAST BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 195. MIDDLE EAST BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 196. MIDDLE EAST BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 197. MIDDLE EAST BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2018-2032 (USD MILLION)
TABLE 198. MIDDLE EAST BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 199. MIDDLE EAST BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2018-2032 (USD MILLION)
TABLE 200. MIDDLE EAST BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 201. MIDDLE EAST BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2018-2032 (USD MILLION)
TABLE 202. MIDDLE EAST BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, 2018-2032 (USD MILLION)
TABLE 203. MIDDLE EAST BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, 2018-2032 (USD MILLION)
TABLE 204. MIDDLE EAST BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 205. AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 206. AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 207. AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2018-2032 (USD MILLION)
TABLE 208. AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 209. AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 210. AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 211. AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2018-2032 (USD MILLION)
TABLE 212. AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 213. AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2018-2032 (USD MILLION)
TABLE 214. AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 215. AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2018-2032 (USD MILLION)
TABLE 216. AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, 2018-2032 (USD MILLION)
TABLE 217. AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, 2018-2032 (USD MILLION)
TABLE 218. AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 219. ASIA-PACIFIC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 220. ASIA-PACIFIC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 221. ASIA-PACIFIC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2018-2032 (USD MILLION)
TABLE 222. ASIA-PACIFIC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 223. ASIA-PACIFIC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 224. ASIA-PACIFIC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 225. ASIA-PACIFIC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2018-2032 (USD MILLION)
TABLE 226. ASIA-PACIFIC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 227. ASIA-PACIFIC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2018-2032 (USD MILLION)
TABLE 228. ASIA-PACIFIC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 229. ASIA-PACIFIC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2018-2032 (USD MILLION)
TABLE 230. ASIA-PACIFIC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, 2018-2032 (USD MILLION)
TABLE 231. ASIA-PACIFIC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, 2018-2032 (USD MILLION)
TABLE 232. ASIA-PACIFIC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 233. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 234. ASEAN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 235. ASEAN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 236. ASEAN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2018-2032 (USD MILLION)
TABLE 237. ASEAN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 238. ASEAN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 239. ASEAN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 240. ASEAN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2018-2032 (USD MILLION)
TABLE 241. ASEAN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 242. ASEAN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2018-2032 (USD MILLION)
TABLE 243. ASEAN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 244. ASEAN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2018-2032 (USD MILLION)
TABLE 245. ASEAN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, 2018-2032 (USD MILLION)
TABLE 246. ASEAN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, 2018-2032 (USD MILLION)
TABLE 247. ASEAN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 248. GCC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 249. GCC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 250. GCC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2018-2032 (USD MILLION)
TABLE 251. GCC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 252. GCC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 253. GCC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 254. GCC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2018-2032 (USD MILLION)
TABLE 255. GCC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 256. GCC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2018-2032 (USD MILLION)
TABLE 257. GCC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 258. GCC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2018-2032 (USD MILLION)
TABLE 259. GCC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, 2018-2032 (USD MILLION)
TABLE 260. GCC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, 2018-2032 (USD MILLION)
TABLE 261. GCC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 262. EUROPEAN UNION BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 263. EUROPEAN UNION BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 264. EUROPEAN UNION BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2018-2032 (USD MILLION)
TABLE 265. EUROPEAN UNION BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 266. EUROPEAN UNION BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 267. EUROPEAN UNION BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 268. EUROPEAN UNION BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2018-2032 (USD MILLION)
TABLE 269. EUROPEAN UNION BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 270. EUROPEAN UNION BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2018-2032 (USD MILLION)
TABLE 271. EUROPEAN UNION BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 272. EUROPEAN UNION BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2018-2032 (USD MILLION)
TABLE 273. EUROPEAN UNION BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, 2018-2032 (USD MILLION)
TABLE 274. EUROPEAN UNION BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, 2018-2032 (USD MILLION)
TABLE 275. EUROPEAN UNION BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 276. BRICS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 277. BRICS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 278. BRICS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2018-2032 (USD MILLION)
TABLE 279. BRICS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 280. BRICS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 281. BRICS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 282. BRICS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2018-2032 (USD MILLION)
TABLE 283. BRICS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 284. BRICS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2018-2032 (USD MILLION)
TABLE 285. BRICS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 286. BRICS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2018-2032 (USD MILLION)
TABLE 287. BRICS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, 2018-2032 (USD MILLION)
TABLE 288. BRICS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, 2018-2032 (USD MILLION)
TABLE 289. BRICS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 290. G7 BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 291. G7 BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 292. G7 BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2018-2032 (USD MILLION)
TABLE 293. G7 BLOOD TRANSFUSION DIAGNOSTICS M

Companies Mentioned

The key companies profiled in this Blood Transfusion Diagnostics market report include:
  • Abbott Laboratories
  • BAG Health Care GmbH
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • Danaher Corporation
  • DiaSorin S.p.A.
  • F. Hoffmann-La Roche Ltd
  • Grifols, S.A.
  • Immucor, Inc.
  • Ortho Clinical Diagnostics, Inc.
  • QuidelOrtho Corporation
  • Quotient Limited
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Werfen S.A.

Table Information

Report AttributeDetails
No. of Pages184
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 4.61 Billion
Forecasted Market Value ( USD ) by 2032 $ 8.32 Billion
Compound Annual Growth Rate10.1%
Regions CoveredGlobal
No. of Companies Mentioned17

Related Topics

Related Reports

Blood Transfusion Diagnostics Market Report 2025 - Product Image

Blood Transfusion Diagnostics Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Donor Transfusion Diagnosis Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Donor Transfusion Diagnosis Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Blood Transfusion Diagnostics - Global Strategic Business Report - Product Image

Blood Transfusion Diagnostics - Global Strategic Business Report

  • Report
  • 173 Pages
  • Global
From
Blood Transfusion Devices Market Report 2025 - Product Image

Blood Transfusion Devices Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Blood Transfusion Devices Market - Global Forecast 2026-2032 - Product Image

Blood Transfusion Devices Market - Global Forecast 2026-2032

  • Report
  • 180 Pages
  • Global
From

About the Market

The Transfusion Diagnostics market is a segment of the In Vitro Diagnostics (IVD) industry. It focuses on the development and production of diagnostic tests used to detect and monitor blood-borne diseases, such as HIV, hepatitis, and syphilis. These tests are used to ensure the safety of blood transfusions and to monitor the health of blood donors. Transfusion Diagnostics tests are used in hospitals, blood banks, and other healthcare settings. The Transfusion Diagnostics market is driven by the increasing demand for safe and reliable blood transfusions, as well as the need for improved patient safety. Additionally, the development of new technologies, such as molecular diagnostics, has enabled the development of more accurate and sensitive tests. Some companies in the Transfusion Diagnostics market include Abbott, Bio-Rad Laboratories, Becton Dickinson, Ortho Clinical Diagnostics, and Siemens Healthineers. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.